Avoro Capital Advisors LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$36,291,000
-7.2%
1,068,0000.0%0.57%
-16.2%
Q2 2021$39,099,000
-2.4%
1,068,000
+19.6%
0.68%
-1.7%
Q1 2021$40,042,000
-46.0%
893,000
-31.3%
0.69%
-45.9%
Q4 2020$74,191,000
-20.5%
1,300,000
-28.6%
1.28%
-3.7%
Q3 2020$93,366,000
-15.9%
1,820,000
-2.2%
1.33%
-39.6%
Q2 2020$111,079,000
+34.9%
1,860,000
-7.0%
2.20%
-21.0%
Q1 2020$82,340,000
+127.9%
2,000,000
+53.8%
2.78%
+161.9%
Q4 2019$36,130,0001,300,0001.06%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders